SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-22-000451
Filing Date
2022-02-14
Accepted
2022-02-14 12:06:44
Documents
1
Group Members
TYBOURNE CAPITAL MANAGEMENT LTDTYBOURNE KESARI LTDVISWANATHAN KRISHNAN

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 sch13ga.htm SC 13G 98345
  Complete submission text file 0000929638-22-000451.txt   100262
Mailing Address 30/F, AIA CENTRAL 1 CONNAUGHT ROAD C HONG KONG K3 XXXXX
Business Address 30/F, AIA CENTRAL 1 CONNAUGHT ROAD C HONG KONG K3 XXXXX 852-3983-6869
TYBOURNE CAPITAL MANAGEMENT (HK) LTD (Filed by) CIK: 0001553936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: K3 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Subject) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91478 | Film No.: 22627849
SIC: 2834 Pharmaceutical Preparations